The SARS-CoV-2 ORF6 protein inhibits nuclear export of mRNA and spliceosomal U snRNA
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0312098 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ichiro Taniguchi. Beteiligte Einrichtung: Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Active Transport, Cell Nucleus, RNA, Messenger, SARS-CoV-2, Spliceosomes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shimizu Foundation for Immunology and Neuroscience, Kao Research Council for the Study of Healthcare Science, Fujiwara Memorial Foundation.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 19 (COVID-19). SARS-CoV-2 infection suppresses host innate immunity and impairs cell viability. Among the viral proteins, ORF6 exhibits potent interferon (IFN) antagonistic activity and cellular toxicity. It also interacts with the RNA export factor RAE1, which bridges the nuclear pore complex and nuclear export receptors, suggesting an effect on RNA export. Using the Xenopus oocyte microinjection system, I found that ORF6 blocked the export of not only mRNA but also spliceosomal U snRNA. I further demonstrated that ORF6 affects the interaction between RAE1 and nuclear export receptors and inhibits the RNA binding of RAE1. These effects of ORF6 may cumulatively block the export of several classes of RNA. I also found that ORF6 binds RNA and forms oligomers. These findings provide insights into the suppression of innate immune responses and the reduction in cell viability caused by SARS-CoV-2 infection, contributing to the development of antiviral drugs targeting ORF6.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
ORCID-Profile: Ichiro Taniguchi
Förderung
- Shimizu Foundation for Immunology and Neuroscience
- Kao Research Council for the Study of Healthcare Science
- Fujiwara Memorial Foundation
- Japan Society for the Promotion of Science
- LiMe Office of Director's Research Grants Program
Zitieren
APA
Taniguchi, I. (2024). The SARS-CoV-2 ORF6 protein inhibits nuclear export of mRNA and spliceosomal U snRNA. PLOS ONE. https://doi.org/10.1371/journal.pone.0312098
Vancouver
Taniguchi I. The SARS-CoV-2 ORF6 protein inhibits nuclear export of mRNA and spliceosomal U snRNA. PLOS ONE. 2024. doi:10.1371/journal.pone.0312098
BibTeX
@article{Taniguchi2024,
author = {Taniguchi, Ichiro},
title = {The SARS-CoV-2 ORF6 protein inhibits nuclear export of mRNA and spliceosomal U snRNA},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0312098}
}
EUVIMED